Valuation: Cegedim

Market Cap 143M 162M 131M 122M 231M 15.43B 235M 1.58B 611M 7.58B 610M 596M 26.36B P/E 2026 *
7.07x
P/E 2027 * 4.7x
Enterprise Value 321M 365M 295M 275M 519M 34.72B 529M 3.55B 1.38B 17.04B 1.37B 1.34B 59.32B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.43x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-2.99%
1 week-5.98%
Current month-2.99%
1 month-9.42%
3 months-15.27%
6 months-23.39%
Current year-23.39%
1 week 10.3
Extreme 10.3
11.28
1 month 10.3
Extreme 10.3
11.7
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
23.55
5 years 8.5
Extreme 8.5
29.8
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Date Insider Type Main position Quantity % Market Cap.
04-27Buy 74,537 0.5287%
04-15Buy 500 0.0035%
03-31Buy 1,239 0.0088%
Change 5-day change 1-year change 3-year change Capi.($)
-2.99%-5.98%+0.29%-51.50% 168M
-2.76%-9.54%-34.92%+19.66% 422B
+5.13%+4.46%-44.88%+12.58% 179B
+6.57%+12.79%-47.72%-5.87% 102B
-3.47%-6.93%-46.53%-2.72% 39.84B
+7.43%-0.79%-74.98%+172.74% 30.56B
+0.99%+5.81%-34.53%+49.11% 27.71B
+3.20%+10.34%-33.28%+27.20% 16.13B
+2.74%+4.87%-31.23%-0.68% 11.93B
+3.74%+15.70%-44.81%+67.78% 10.24B
Average +1.82%+1.93%-39.26%+28.83% 83.98B
Weighted average by Cap. +2.14%-3.24%-40.63%+20.95%

Financials

2026 *2027 *
Net sales 660M 752M 608M 566M 1.07B 71.51B 1.09B 7.31B 2.83B 35.1B 2.82B 2.76B 122B 681M 776M 627M 584M 1.1B 73.76B 1.12B 7.54B 2.92B 36.21B 2.91B 2.85B 126B
Net income 21.25M 24.2M 19.56M 18.23M 34.37M 2.3B 35.07M 235M 91.15M 1.13B 90.87M 88.91M 3.93B 30.58M 34.83M 28.15M 26.23M 49.47M 3.31B 50.48M 339M 131M 1.63B 131M 128M 5.66B
Net Debt 178M 203M 164M 153M 288M 19.29B 294M 1.97B 764M 9.47B 762M 745M 32.95B 150M 171M 138M 128M 242M 16.22B 247M 1.66B 642M 7.96B 640M 627M 27.7B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-07-01 €10.38 -2.99% 11,537
26-06-30 €10.70 -1.47% 4,283
26-06-29 €10.86 -1.63% 5,563
26-06-26 €11.04 -1.43% 6,826
26-06-25 €11.20 +1.45% 1,024
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
10.38EUR
Average target price
15.00EUR
Spread / Average Target
+44.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock